Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0M1YU
|
||||
| Former ID |
DNC006151
|
||||
| Drug Name |
VER-2692
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [527833] | ||
| Formula |
C14H15N3
|
||||
| Canonical SMILES |
CC(CN1C=CC2=C1C3=C(C=C2)N=CC=C3)N
|
||||
| InChI |
1S/C14H15N3/c1-10(15)9-17-8-6-11-4-5-13-12(14(11)17)3-2-7-16-13/h2-8,10H,9,15H2,1H3/t10-/m0/s1
|
||||
| InChIKey |
SDEXYLCQNBTWLI-JTQLQIEISA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 2A receptor | Target Info | Inhibitor | [527833] | |
| 5-hydroxytryptamine 2B receptor | Target Info | Inhibitor | [527833] | ||
| 5-hydroxytryptamine 2C receptor | Target Info | Inhibitor | [527833] | ||
| WikiPathways | Serotonin Receptor 2 and STAT3 Signaling | ||||
| Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | |||||
| SIDS Susceptibility Pathways | |||||
| Monoamine GPCRs | |||||
| GPCRs, Class A Rhodopsin-like | |||||
| Gastrin-CREB signalling pathway via PKC and MAPK | |||||
| GPCR ligand binding | |||||
| GPCR downstream signaling | |||||
| GPCRs, OtherWP732:Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | |||||
| GPCR downstream signalingWP732:Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.